英文名: 15-keto Prostaglandin A1 英文别名: 15-keto PGA1;15-keto Prostaglandin A1;Prosta-10,13-dien-1-oic acid, 9,15-dioxo-, (13E)- (9CI) 中文名: 15-keto Prostaglandin A1 中文别名: CBNumber: CB44666875 分子式: C20H30O4 分子量: 334.45 MOL File: 61600-67-7.mol 化学...
15-keto Prostaglandin A1详情 评价(0) 货号: ajci66448 CAS: 61600-67-7 别名: 15keto PGA1 分子式: C20H30O4 分子量: 334.5 纯度: >98% 溶解度: DMF: 50 mg/ml,DMSO: 50 mg/ml,Ethanol: 50 mg/ml,PBS (pH 7.2): 1 mg/ml 储存: Store at -20°C 库存: 现货 Backgrou...
英文名字 9,15-dioxo-prosta-10,13E-dien-1-oic acid; 15-keto PGA1; 15-keto Prostaglandin A1 供应商 Cayman Chemical 产品货号 9000142-500 产品报价 ￥询价/500ug 产品说明书 点击查看 购买方式 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868 ...
In an aqueous composition comprising a 15-keto-prostaglandin compound as an active ingredient, a polyoxyethylene castor oil derivative, which is polyoxyethylene 35 castor oil, is admixed. By admixing a polyoxyethylene castor oil derivative, the solubility of the 15-keto-PG compound in water is ...
1. The use of 15 ethyl prostaglandin compounds to produce a drug for the treatment of patients with disease or related people, or for the treatment of biliary disorders, or for the treatment of liver transplantation in the process of transplantation. 展开 ...
Prostaglandin E1 (PGE1) is successfully used in the treatment of arterial occlusive diseases. Besides inhibitory effects on blood cells, e. g., platelets and neutrophils, arterial relaxation might be beneficial for its therapeutic use. In vivo, a decreas
The release of prostaglandin F2α as reflected by 15-keto-13,14-dihydroprostaglandin F2α in the peripheral circulation during normal luteolysis in heifers... Based on the widespread use of homeopathy in treatment of animal disease and the poor documentation of its possible effects and consequences...
15-keto Prostaglandin A1详情 评价(0) 货号: ajci66448 CAS: 61600-67-7 别名: 15keto PGA1 分子式: C20H30O4 分子量: 334.5 纯度: >98% 溶解度: DMF: 50 mg/ml,DMSO: 50 mg/ml,Ethanol: 50 mg/ml,PBS (pH 7.2): 1 mg/ml 储存: Store at -20°C 库存: 现货 Backgrou...
The method or composition of the present invention induces substantially no hair growth, which is a know side effect of conventional prostaglandin ophthalmic compounds such as latanoprost.doi:WO2004071514 A1Habe, TsuyoshiSekida, TakashiWOWO2004071514A1 * Feb 13, 2004 Aug 26, 2004 Tsuyoshi Habe 15...
An ophthalmic composition comprising a prostaglandin compound and a thickening compound. This composition, by virtue of the addition of a thickening compound, realizes stabler exertion of the activity and effect of prostaglandin compound and further enhances the continuity of the activity and effect and...